C
Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
C
Hold
9/29/2023Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from C- on 9/29/2023 due to an increase in the dividend index and valuation index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from C- on 9/29/2023 due to an increase in the dividend index and valuation index.
C
Hold
8/22/2023Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to C- from C on 8/22/2023 due to a decline in the efficiency index, solvency index and volatility index. Debt to equity increased from 0.57 to 0.58.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to C- from C on 8/22/2023 due to a decline in the efficiency index, solvency index and volatility index. Debt to equity increased from 0.57 to 0.58.
C
Hold
4/6/2023Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from C- on 4/6/2023 due to an increase in the volatility index and efficiency index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from C- on 4/6/2023 due to an increase in the volatility index and efficiency index.
C
Hold
10/26/2022Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to C- from C on 10/26/2022 due to a decline in the volatility index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to C- from C on 10/26/2022 due to a decline in the volatility index.
C
Hold
9/9/2019Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from C- on 9/9/2019 due to an increase in the volatility index and total return index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from C- on 9/9/2019 due to an increase in the volatility index and total return index.
C
Hold
9/5/2019Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D+ on 9/5/2019 due to a large increase in the growth index, efficiency index and volatility index. EBIT increased 6.52% from $31.1M to $33.12M, total revenue increased 4.9% from $163.42M to $171.43M, and total capital increased 3.59% from $705.62M to $730.93M.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D+ on 9/5/2019 due to a large increase in the growth index, efficiency index and volatility index. EBIT increased 6.52% from $31.1M to $33.12M, total revenue increased 4.9% from $163.42M to $171.43M, and total capital increased 3.59% from $705.62M to $730.93M.
D
Sell
5/17/2019Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to D+ from D on 5/17/2019 due to a major increase in the growth index and efficiency index. Earnings per share increased from $0.0085 to $0.013, total revenue increased 22.08% from $133.86M to $163.42M, and net income increased 18.87% from $11.05M to $13.14M.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to D+ from D on 5/17/2019 due to a major increase in the growth index and efficiency index. Earnings per share increased from $0.0085 to $0.013, total revenue increased 22.08% from $133.86M to $163.42M, and net income increased 18.87% from $11.05M to $13.14M.
D
Sell
11/14/2018Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D from C- on 11/14/2018 due to a noticeable decline in the volatility index, efficiency index and total return index. Net income declined 27.19% from $15.44M to $11.24M.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D from C- on 11/14/2018 due to a noticeable decline in the volatility index, efficiency index and total return index. Net income declined 27.19% from $15.44M to $11.24M.
C
Hold
10/18/2018Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D+ on 10/18/2018 due to an increase in the valuation index and volatility index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D+ on 10/18/2018 due to an increase in the valuation index and volatility index.
D
Sell
8/3/2018Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D+ from C- on 8/3/2018 due to a large decline in the growth index and total return index. Earnings per share declined from $0.0214 to $0.016, EBIT declined 10.05% from $35.61M to $32.03M, and total revenue declined 0.91% from $161.49M to $160.02M.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D+ from C- on 8/3/2018 due to a large decline in the growth index and total return index. Earnings per share declined from $0.0214 to $0.016, EBIT declined 10.05% from $35.61M to $32.03M, and total revenue declined 0.91% from $161.49M to $160.02M.
C
Hold
7/23/2018Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to C- from C on 7/23/2018 due to a decline in the total return index and solvency index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to C- from C on 7/23/2018 due to a decline in the total return index and solvency index.
C
Hold
5/14/2018Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from D+ on 5/14/2018 due to an increase in the valuation index, growth index and solvency index. The quick ratio increased from 0.96 to 1.42, earnings per share increased from $0.0186 to $0.0214, and total revenue increased 6.11% from $152.18M to $161.49M.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C from D+ on 5/14/2018 due to an increase in the valuation index, growth index and solvency index. The quick ratio increased from 0.96 to 1.42, earnings per share increased from $0.0186 to $0.0214, and total revenue increased 6.11% from $152.18M to $161.49M.
D
Sell
5/2/2018Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to D+ from D on 5/2/2018 due to a large increase in the valuation index, efficiency index and growth index. Operating cash flow increased 109.22% from $10.38M to $21.71M, net income increased 38.04% from $12.94M to $17.86M, and earnings per share increased from $0.0135 to $0.0186.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to D+ from D on 5/2/2018 due to a large increase in the valuation index, efficiency index and growth index. Operating cash flow increased 109.22% from $10.38M to $21.71M, net income increased 38.04% from $12.94M to $17.86M, and earnings per share increased from $0.0135 to $0.0186.
D
Sell
2/5/2018Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D from D+ on 2/5/2018 due to a decline in the volatility index and total return index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D from D+ on 2/5/2018 due to a decline in the volatility index and total return index.
D
Sell
12/21/2017Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D+ from C- on 12/21/2017 due to a decline in the volatility index and total return index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D+ from C- on 12/21/2017 due to a decline in the volatility index and total return index.
C
Hold
11/28/2017Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D+ on 11/28/2017 due to an increase in the valuation index and volatility index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D+ on 11/28/2017 due to an increase in the valuation index and volatility index.
D
Sell
11/13/2017Downgrade
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D+ from C- on 11/13/2017 due to a noticeable decline in the total return index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was downgraded to D+ from C- on 11/13/2017 due to a noticeable decline in the total return index.
C
Hold
10/27/2017Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D on 10/27/2017 due to a major increase in the total return index, valuation index and volatility index.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to C- from D on 10/27/2017 due to a major increase in the total return index, valuation index and volatility index.
D
Sell
12/22/2016Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 12/22/2016 due to a decline in the volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 12/22/2016 due to a decline in the volatility index.
D
Sell
11/28/2016Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 11/28/2016 due to an increase in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 11/28/2016 due to an increase in the volatility index and total return index.
D
Sell
11/11/2016Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 11/11/2016 due to a decline in the total return index and volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 11/11/2016 due to a decline in the total return index and volatility index.
D
Sell
10/21/2016Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 10/21/2016 due to an increase in the total return index and volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 10/21/2016 due to an increase in the total return index and volatility index.
D
Sell
10/6/2016Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 10/6/2016 due to a decline in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 10/6/2016 due to a decline in the volatility index and total return index.
D
Sell
9/21/2016Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 9/21/2016 due to a major increase in the total return index, volatility index and solvency index. The quick ratio increased from 2.24 to 2.42.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 9/21/2016 due to a major increase in the total return index, volatility index and solvency index. The quick ratio increased from 2.24 to 2.42.
D
Sell
5/4/2016Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 5/4/2016 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 1,038.36% from $11.11M to -$104.29M, earnings per share declined from $0.0108 to -$0.0997, and EBIT declined 701.8% from $21.89M to -$131.74M.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 5/4/2016 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 1,038.36% from $11.11M to -$104.29M, earnings per share declined from $0.0108 to -$0.0997, and EBIT declined 701.8% from $21.89M to -$131.74M.
D
Sell
4/13/2016Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 4/13/2016 due to an increase in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to D+ from D on 4/13/2016 due to an increase in the volatility index and total return index.
D
Sell
3/28/2016Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 3/28/2016 due to a decline in the total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D from D+ on 3/28/2016 due to a decline in the total return index.
D
Sell
3/11/2016Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and efficiency index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index, total return index and efficiency index.
C
Hold
11/2/2015Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C from C+ on 11/2/2015 due to a decline in the growth index, solvency index and efficiency index. Earnings per share declined from $0.0226 to $0.0104, net income declined 52.51% from $23.4M to $11.11M, and EBIT declined 40.89% from $37.03M to $21.89M.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C from C+ on 11/2/2015 due to a decline in the growth index, solvency index and efficiency index. Earnings per share declined from $0.0226 to $0.0104, net income declined 52.51% from $23.4M to $11.11M, and EBIT declined 40.89% from $37.03M to $21.89M.
C
Hold
6/12/2015Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to C+ from C on 6/12/2015 due to a noticeable increase in the growth index, valuation index and efficiency index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to C+ from C on 6/12/2015 due to a noticeable increase in the growth index, valuation index and efficiency index.
C
Hold
5/1/2015Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C from C+ on 5/1/2015 due to a substantial decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.0344 to $0.0089, the quick ratio declined from 2.95 to 0.94, and EBIT declined 55.58% from $62.78M to $27.89M.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C from C+ on 5/1/2015 due to a substantial decline in the growth index, valuation index and solvency index. Earnings per share declined from $0.0344 to $0.0089, the quick ratio declined from 2.95 to 0.94, and EBIT declined 55.58% from $62.78M to $27.89M.
C
Hold
2/23/2015Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C+ from B- on 2/23/2015 due to a noticeable decline in the total return index and volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C+ from B- on 2/23/2015 due to a noticeable decline in the total return index and volatility index.
B
Buy
1/6/2015Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B- from C+ on 1/6/2015 due to an increase in the valuation index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B- from C+ on 1/6/2015 due to an increase in the valuation index.
C
Hold
12/22/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C+ from B- on 12/22/2014 due to a noticeable decline in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C+ from B- on 12/22/2014 due to a noticeable decline in the volatility index and total return index.
B
Buy
11/25/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B- from B on 11/25/2014 due to a decline in the volatility index, total return index and valuation index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B- from B on 11/25/2014 due to a decline in the volatility index, total return index and valuation index.
B
Buy
11/10/2014Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B from B- on 11/10/2014 due to an increase in the volatility index and valuation index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B from B- on 11/10/2014 due to an increase in the volatility index and valuation index.
B
Buy
10/24/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B- from B on 10/24/2014 due to a significant decline in the growth index, volatility index and solvency index. The quick ratio declined from 3.04 to 2.95, and debt to equity increased from 0.66 to 0.67.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B- from B on 10/24/2014 due to a significant decline in the growth index, volatility index and solvency index. The quick ratio declined from 3.04 to 2.95, and debt to equity increased from 0.66 to 0.67.
B
Buy
9/18/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 9/18/2014 due to a decline in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 9/18/2014 due to a decline in the volatility index and total return index.
B
Buy
9/10/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B+ from A- on 9/10/2014 due to a decline in the total return index and volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B+ from A- on 9/10/2014 due to a decline in the total return index and volatility index.
A
Buy
8/26/2014Upgraded
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to A- from B on 08/26/2014.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) was upgraded to A- from B on 08/26/2014.
B
Buy
8/11/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 8/11/2014 due to a decline in the volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 8/11/2014 due to a decline in the volatility index.
B
Buy
7/25/2014Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B+ from B on 7/25/2014 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from $0.0111 to $0.0226, EBIT increased 67.86% from $27.01M to $45.33M, and total revenue increased 21.08% from $184.24M to $223.07M.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B+ from B on 7/25/2014 due to a significant increase in the growth index, total return index and volatility index. Earnings per share increased from $0.0111 to $0.0226, EBIT increased 67.86% from $27.01M to $45.33M, and total revenue increased 21.08% from $184.24M to $223.07M.
B
Buy
7/3/2014Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B from B- on 7/3/2014 due to an increase in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B from B- on 7/3/2014 due to an increase in the volatility index and total return index.
B
Buy
7/1/2014Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B- from C on 7/1/2014 due to an increase in the total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B- from C on 7/1/2014 due to an increase in the total return index.
C
Hold
6/30/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C from B on 6/30/2014 due to a noticeable decline in the volatility index, solvency index and valuation index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to C from B on 6/30/2014 due to a noticeable decline in the volatility index, solvency index and valuation index.
B
Buy
5/5/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 5/5/2014 due to a decline in the growth index, total return index and efficiency index. Net income declined 82.07% from $64.63M to $11.59M, earnings per share declined from $0.0614 to $0.0111, and EBIT declined 73.39% from $101.5M to $27.01M.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 5/5/2014 due to a decline in the growth index, total return index and efficiency index. Net income declined 82.07% from $64.63M to $11.59M, earnings per share declined from $0.0614 to $0.0111, and EBIT declined 73.39% from $101.5M to $27.01M.
B
Buy
4/23/2014Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B+ from B on 4/23/2014 due to an increase in the volatility index.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B+ from B on 4/23/2014 due to an increase in the volatility index.
B
Buy
4/8/2014Downgrade
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 4/8/2014 due to a decline in the volatility index and total return index.
Genomma Lab Internacional SAB de CV (GNMLF) was downgraded to B from B+ on 4/8/2014 due to a decline in the volatility index and total return index.
B
Buy
2/28/2014Upgraded
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B+ from D+ on 2/28/2014 due to an increase in stability, valuation and growth.
Genomma Lab Internacional SAB de CV (GNMLF) was upgraded to B+ from D+ on 2/28/2014 due to an increase in stability, valuation and growth.
OTC PK
02/06/2025 10:34AM Eastern
Quotes delayed
